Company Filing History:
1 out of 23 
1 out of 81 
1 out of 3 Years Active: 2022
Title: The Innovative Contributions of Dominic Howard Banda
Introduction
Dominic Howard Banda is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of antiviral agents through his innovative research and development. His work focuses on novel labyrinthopeptin derivatives that have the potential to treat various infectious diseases.
Latest Patents
Dominic Howard Banda holds a patent for "Labyrinthopeptins as anti-viral agents." This invention relates to novel labyrinthopeptin derivatives that are useful for treating infectious diseases caused by viruses such as human respiratory syncytial virus (RSV), Kaposi sarcoma-associated herpesvirus (KSHV), cytomegalovirus (CMV), dengue virus (DENV), chikungunya virus (CHIKV), tick-borne encephalitis virus (TBEV), vesicular stomatitis Indiana virus (VSV), zika virus (ZIKV), and hepatitis C virus (HCV). The labyrinthopeptin derivatives are also valuable for analyzing the mode of action of labyrinthopeptins. Furthermore, the invention includes a combination of labyrinthopeptin A1 and A2 for use as a medicament in treating infectious diseases caused by these viruses.
Career Highlights
Throughout his career, Dominic Howard Banda has worked with esteemed organizations such as Helmholtz-Zentrum für Infektionsforschung GmbH and Medizinische Hochschule Hannover. His experience in these institutions has contributed to his expertise in the field of infectious diseases and antiviral research.
Collaborations
Dominic has collaborated with notable colleagues, including Mark Brönstrup and Hans-Peter Prochnow. These collaborations have further enhanced his research and development efforts in the field of antiviral agents.
Conclusion
Dominic Howard Banda's innovative work in developing labyrinthopeptin derivatives showcases his commitment to advancing antiviral treatments. His contributions are significant in the ongoing fight against infectious diseases.